# Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer

> **NCT00367679** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 35 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer
- Lung Cancer, Non-Small Cell

## Interventions

- **DRUG:** Pazopanib

## Key facts

- **NCT ID:** NCT00367679
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2012-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00367679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00367679, "Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00367679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*